Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease 3 min read Health Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease bestpressreleaseagency 5 months ago Noida, India — 15 January, 2026 – Ikris Pharma Network announced the availability of Triokris™ (Trientine Dihydrochloride 250 mg Capsules), a therapeutic option for patients... Read More
Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease 